BridgeBio Pharma, Inc 10-Q for FY2022 Q1
BridgeBio Pharma, Inc. (BBIO)
10-Q
2022-05-05
For: 2022-03-31
View Original
Added on
April 08, 2026
About this 10-Q
BridgeBio Pharma, Inc filed this 10-Q on May 5, 2022, covering the quarter ended March 31, 2022 (FY2022 Q1).
Headline figures
Quarter ended March 31, 2022, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $1.69M
- up 266.7% from $462K a year earlier
- Net loss
- $201.33M
- compared with a net loss of $171.08M a year earlier